Cigna earnings beat by $0.04, revenue topped estimates
Neville Daniel, the Chief Executive Officer of Advanced Flower Capital Inc. (NASDAQ:AFCG), recently acquired 5,000 shares of the company’s common stock. The transaction took place on March 28, 2025, at a price of $6.15 per share, amounting to a total purchase value of $30,750. The purchase comes as the stock trades near its 52-week low of $5.44, with InvestingPro analysis indicating the shares are currently undervalued. Following this acquisition, Daniel’s direct ownership in the company increased to 187,261 shares. This move comes as part of Daniel’s ongoing engagement with the company, headquartered in West Palm Beach, Florida. The stock currently offers an attractive 16.5% dividend yield, and technical indicators suggest oversold conditions. For deeper insights into insider trading patterns and comprehensive analysis, InvestingPro subscribers can access the detailed Pro Research Report, available for over 1,400 US stocks.
In other recent news, Advanced Flower Capital (AFCG) reported fourth-quarter 2024 earnings that fell short of expectations, with earnings per share (EPS) at $0.29, missing the consensus forecast of $0.3683. Revenue also did not meet projections, coming in at $7.64 million compared to the anticipated $11.59 million. The shortfall in earnings is primarily attributed to reduced interest income linked to loans currently in default. The company faces challenges with non-performing loans, totaling 39% of its portfolio, which has affected its dividend, now reduced to $0.23 per share.
Analyst reactions to these financial results have been mixed. Jefferies downgraded the stock from Buy to Hold, citing credit concerns and adjusting the price target to $7.00 from $10.00. Meanwhile, Citizens JMP maintained a Market Perform rating, suggesting the current stock price reflects the credit issues. Despite these hurdles, Advanced Flower Capital has a strong pipeline of over $380 million in potential deals, focusing on lending to established cannabis operators. The company’s future financial health and stock performance are closely tied to its ability to recover defaulted funds and stabilize its loan portfolio.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.